ARDM Aradigm to Host Conference Call
Wednesday August 6, 1:01 pm ET
HAYWARD, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Aradigm Corporation (Nasdaq: ARDM - News) will host a conference call and question and answer session on Wednesday, August 6, 2003 to provide additional perspective on the status of manufacturing for the AERx iDMS program.
Date: Wednesday, August 6, 2003
Time: 2:30 p.m. Eastern, 11:30 a.m. Pacific
Internet: The live webcast can be accessed at www.aradigm.com
Telephone: 866-297-6391
International callers, dial +1-847-944-7313
A playback of this conference call will be available beginning at 5:30 p.m. ET, Wednesday, August 6, 2003, which can be accessed on www.aradigm.com or by dialing 877-213-9653. International callers should dial +1-630-652-3041. The replay passcode is 7558149.
Aradigm is working to improve the quality of life for patients by developing delivery alternatives for traditional injectable therapies. The company's advanced technologies provide leading pharmaceutical and biotech partners with effective drug delivery solutions. The company's two technologies are the AERx® Pulmonary Drug Delivery System and the Intraject® needle-less injector system. Based in Hayward, California, Aradigm's lead development program is inhaled insulin for diabetes management, which is partnered with Novo Nordisk, the world leader in insulin and diabetes care. More information about Aradigm can be found at www.aradigm.com.
CONTACT: media, Chris Keenan of Aradigm Corporation, +1-510-265-9370; or investors, Joe Dorame of RCG Capital Markets, +1-480-675-0400, for Aradigm Corporation. |
